SparingVision's Unattributed Round

SparingVision raised a round of funding on July 10, 2017.

SparingVision is a biotechnology company focused on the discovering and development of a therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa.…

Articles about SparingVision's Unattributed Round: